Pharmaceutical companies largely avoid social media involvement, cowering from regulatory wrath. They fear a loss of messaging control, privacy concerns and a lack of familiarity with community building. In addition, they struggle to quantify a return on investment. So how do they actually know what physicians are saying about their drug? Social media monitoring and understanding your stakeholders’ key demographics has never been more valuable.